PAB should be $100m market cap at time of clinical trials. yearly highs to be broken.
https://www.patrys.com/site/in-the-news/Bioshares_PAB_28Sept2020.pdf
"Patrys expects its lead compound to enter clinical studies towards the end of next year. A transaction for its lead program may occur before then."
- Forums
- ASX - By Stock
- Ann: PAB Business Review - 30 June 2020
PAB should be $100m market cap at time of clinical trials....
Featured News
Add PAB (ASX) to my watchlist
|
|||||
Last
0.7¢ |
Change
0.001(7.69%) |
Mkt cap ! $14.40M |
Open | High | Low | Value | Volume |
0.7¢ | 0.7¢ | 0.7¢ | $17.34K | 2.497M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
22 | 6470626 | 0.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.8¢ | 1004952 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
22 | 6470626 | 0.006 |
21 | 8280275 | 0.005 |
9 | 4927451 | 0.004 |
8 | 6400016 | 0.003 |
1 | 2520000 | 0.002 |
Price($) | Vol. | No. |
---|---|---|
0.008 | 1004952 | 2 |
0.009 | 1766604 | 3 |
0.010 | 1412000 | 3 |
0.011 | 1080000 | 2 |
0.012 | 1558283 | 5 |
Last trade - 15.56pm 23/07/2024 (20 minute delay) ? |
Featured News
PAB (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & MD
Charles Armstrong
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online